𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Epigenetic and genetic analysis of the survivin promoter in acute myeloid leukemia

✍ Scribed by Mandy Wagner; Karin Schmelz; Bernd Dörken; Ingo Tamm

Publisher
Elsevier Science
Year
2008
Tongue
English
Weight
478 KB
Volume
32
Category
Article
ISSN
0145-2126

No coin nor oath required. For personal study only.

✦ Synopsis

Survivin, an inhibitor of apoptosis (IAP) protein plays a dual role in regulation of mitosis and inhibition of apoptosis. Survivin is expressed in embryonic and fetal organs as well as in most human cancers, but not in normal differentiated adult tissues. In this study we investigated the molecular mechanism involved in overexpression of survivin in acute myeloid leukemia (AML). We used methylation specific PCR (MSP) and bisulfite sequencing to analyze the methylation status of the survivin promoter in primary AML samples and normal peripheral blood mononuclear cells (PBMCs). Both, in patients with de novo AML and normal control samples an unmethylated survivin promoter was present. Mutational analysis of the proximal survivin promoter revealed three single nucleotide polymorphisms (SNPs), where the frequently occurred polymorphism (G/C) at position -31 was detectable in both, AML blasts and healthy PBMCs and showed no significant impact on prognosis in de novo AML patients. These results suggest that the methylation status of the survivin promoter and occurrence of these SNPs within the promoter region of the survivin gene appear to be of minor importance in leukemogenesis.

📜 SIMILAR VOLUMES

In vivo expression of survivin and its s
In vivo expression of survivin and its splice variant survivin-2B: Impact on clinical outcome in acute myeloid leukemia
✍ Mandy Wagner; Karin Schmelz; Christian Wuchter; Wolf-Dieter Ludwig; Bernd Dörken 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 229 KB 👁 1 views

## Abstract Survivin, a member of the inhibitor of apoptosis protein family, is expressed in most human cancers, but undetectable in normal differentiated adult tissue __in vivo__. Because of this cancer‐related expression, survivin is a promising target for cancer therapy. To determine the express

Epigenetic regulation of signal transduc
Epigenetic regulation of signal transducer and activator of transcription 3 in acute myeloid leukemia
✍ Sampa Ghoshal (Gupta); Heinz Baumann; Meir Wetzler 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 350 KB

We have demonstrated that constitutive signal transducer and activator of transcription (STAT) 3 activity, observed in approximately 50% of acute myeloid leukemia (AML) cases, is associated with adverse treatment outcome. Constitutive STAT3 activation may result from the expression of oncogenic prot

Mutation analysis of PTEN/MMAC1 in acute
Mutation analysis of PTEN/MMAC1 in acute myeloid leukemia
✍ Liu, Ta-Chih; Lin, Pai-Mei; Chang, Jan-Gowth; Lee, Jing-Ping; Chen, Tyen-Po; Lin 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 285 KB 👁 2 views

Recently, a putative tumor suppressor gene, PTEN/MMAC1, has been identified at chromosome 10q23.3, which encodes a 403 amino acid dual-specificity phosphatase containing a region of homology to tensin and auxillin. Somatic mutations of the PTEN/MMAC1 gene have been identified in a number of cancer c

Progress in the treatment of acute myelo
Progress in the treatment of acute myeloid leukemia
✍ Farhad Ravandi; Alan K. Burnett; Edward D. Agura; Hagop M. Kantarjian 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 131 KB 👁 2 views

## Abstract Significant progress in understanding the mechanisms leading to the development of acute myeloid leukemia (AML) has led to the identification of numerous molecular abnormalities that may be responsible for leukemogenesis. Over the same period, large trials have established standard regi